Aptus Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.2M | Buy |
201,691
+8,547
| +4% | +$1.99M | 0.35% | 63 |
|
|
2026
Q1 | $47.2M | Sell |
193,144
-6,081
| -3% | -$1.42M | 0.37% | 55 |
|
|
2025
Q4 | $41.2M | Buy |
199,225
+34,831
| +21% | +$6.89M | 0.3% | 66 |
|
|
2025
Q3 | $30.5M | Buy |
164,394
+1,910
| +1% | +$327K | 0.22% | 90 |
|
|
2025
Q2 | $24.8M | Buy |
162,484
+5,978
| +4% | +$919K | 0.2% | 103 |
|
|
2025
Q1 | $26M | Sell |
156,506
-12,753
| -8% | -$2M | 0.27% | 80 |
|
|
2024
Q4 | $24.5M | Buy |
169,259
+22,696
| +15% | +$3.52M | 0.26% | 87 |
|
|
2024
Q3 | $23.8M | Buy |
146,563
+42,059
| +40% | +$6.7M | 0.35% | 68 |
|
|
2024
Q2 | $15.3M | Buy |
104,504
+19,871
| +23% | +$2.96M | 0.27% | 83 |
|
|
2024
Q1 | $13.4M | Buy |
84,633
+10,399
| +14% | +$1.66M | 0.25% | 86 |
|
|
2023
Q4 | $11.6M | Sell |
74,234
-8,349
| -10% | -$1.28M | 0.32% | 76 |
|
|
2023
Q3 | $12.9M | Buy |
82,583
+3,345
| +4% | +$552K | 0.35% | 64 |
|
|
2023
Q2 | $13.1M | Sell |
79,238
-4,223
| -5% | -$682K | 0.31% | 71 |
|
|
2023
Q1 | $12.9M | Sell |
83,461
-5,257
| -6% | -$849K | 0.35% | 60 |
|
|
2022
Q4 | $15.7M | Buy |
88,718
+11,218
| +14% | +$1.94M | 0.48% | 44 |
|
|
2022
Q3 | $12.7M | Buy |
77,500
+5,177
| +7% | +$876K | 0.3% | 48 |
|
|
2022
Q2 | $12.8M | Buy |
72,323
+6,054
| +9% | +$1.08M | 0.33% | 41 |
|
|
2022
Q1 | $11.7M | Buy |
66,269
+10,440
| +19% | +$1.78M | 0.29% | 45 |
|
|
2021
Q4 | $9.55M | Buy |
55,829
+2,198
| +4% | +$360K | 0.29% | 54 |
|
|
2021
Q3 | $8.66M | Buy |
53,631
+7,048
| +15% | +$1.2M | 0.22% | 55 |
|
|
2021
Q2 | $7.67M | Buy |
46,583
+4,484
| +11% | +$742K | 0.22% | 55 |
|
|
2021
Q1 | $6.92M | Sell |
42,099
-5,061
| -11% | -$819K | 0.25% | 56 |
|
|
2020
Q4 | $7.42M | Buy |
47,160
+6,485
| +16% | +$957K | 0.34% | 55 |
|
|
2020
Q3 | $6.05M | Buy |
40,675
+2,689
| +7% | +$398K | 0.32% | 59 |
|
|
2020
Q2 | $5.34M | Sell |
37,986
-430
| -1% | -$62.7K | 0.34% | 54 |
|
|
2020
Q1 | $5.04M | Sell |
38,416
-5,069
| -12% | -$719K | 0.44% | 44 |
|
|
2019
Q4 | $6.34M | Buy |
43,485
+20,332
| +88% | +$2.76M | 0.45% | 42 |
|
|
2019
Q3 | $3M | Buy |
23,153
+16,819
| +266% | +$2.22M | 0.17% | 59 |
|
|
2019
Q2 | $882K | Sell |
6,334
-976
| -13% | -$135K | 0.12% | 132 |
|
|
2019
Q1 | $1.02M | Buy |
+7,310
| New | +$979K | 0.17% | 113 |
|
Other funds holding JNJ
Aptus Capital Advisors's JNJ Position: Q2 2026 in Review
Aptus Capital Advisors increased its Johnson & Johnson (JNJ) stake by 4.4% in Q2 2026, buying an estimated $1.99M and bringing the position to 201,691 shares worth $51.2M. The position accounts for 0.35% of the portfolio, ranked #63.
Aptus Capital Advisors first reported a position in JNJ in Q1 2019 and has held it in 30 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Aptus Capital Advisors held 201,691 shares of Johnson & Johnson worth $51.2M as of Q2 2026.
- Aptus Capital Advisors bought 8,547 Johnson & Johnson shares in Q2 2026, an estimated $1.99M.
- Johnson & Johnson made up 0.35% of Aptus Capital Advisors's portfolio in Q2 2026, its #63 holding.
- Aptus Capital Advisors first reported a position in Johnson & Johnson in Q1 2019 and has held it in 30 quarters since.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.